IGI receives CIRM CESCG CRP grant to study gene correction for SCD

The IGI has been awarded a CIRM grant to develop next-generation sequencing approaches to track gene correction in bone marrow stem cells for the treatment of sickle cell disease. The CIRM Center of Excellence in Stem Cell Genomics (CESCG) Collaborative Research Program (CRP) supports collaborative research projects by providing California scientists with access to cutting-edge genomics and bioinformatics technologies, and expertise and assistance in experimental design and data analysis. Working with CESCG, the IGI will determine how bone marrow stem cells respond to genetic engineering, characterize on- and off-target gene editing in these challenging cells, and work to move research on a gene editing cure for sickle cell disease closer to the clinic.

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

April 10, 2025

SYNTHETIC LETHALITY IN DNA DAMAGE RESPONSE- PUBLISHED IN NATURE

The DNA damage response (DDR) protects the genome from myriad insults. Indeed, because endogenous damage is an existential and continual threat, cells achieve...

February 26, 2025

Welcome to Rafaela!

Rafaela received her Master’s degree in Bioengineering from the University of Engineering of Porto in 2019, where she worked on the production and characterization...

February 24, 2025

Welcome to Boris!

Boris Korablev received his Bachelor’s degree in Molecular and Cell Biology from UC Berkeley in 2021. Before joining ETH, he worked at a gene-editing...

News Archive

Tweets